Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome

@inproceedings{Glintborg2017EffectOO,
  title={Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome},
  author={Dorte Glintborg and Hanne Mumm and Jens Juul Holst and Marianne E Andersen},
  booktitle={Endocrine connections},
  year={2017}
}
CONTEXT Insulin resistance in polycystic ovary syndrome (PCOS) may increase the risk of reactive hypoglycaemia (RH) and decrease glucagon-like peptide-1 (GLP-1) secretion. The possible effects of treatment with oral contraceptives (OCP) and/or metformin on GLP-1 secretion and risk of RH in PCOS is undetermined. SETTING Outpatient clinic. PATIENTS AND INTERVENTIONS Randomized, controlled clinical trial. Ninety women with PCOS were randomized to 12-month treatment with OCP (150 mg desogestrel… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

Measurement of the incretin hormones: glucagonlike peptide-1 and glucose-dependent insulinotropic peptide

  • RE Kuhre, NJ Wewer Albrechtsen, B Hartmann, CF Deacon, JJ. Holst
  • Journal of Diabetes and its Complications
  • 2015

Similar Papers

Loading similar papers…